Once there is a working vaccine, manufacturers across the globe will need to scale up production to produce billions of doses — this means billions of pharmaceutical-grade glass vials, rubber stoppers, packaging and storage and refrigeration. Plus: ensuring the vaccine is available to people the world over. Hosts Luiza Savage and Ryan Heath question experts on how different countries are handling this overwhelming challenge. Subscribe to POLITICO'S Global Translations for the full series.